Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

NCT01303705 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Cancer of the Prostate
Prostate Cancer

Interventions

DRUG: Anti-OX40
RADIATION: Radiation
DRUG: Cyclophosphamide

Sponsor

Providence Health & Services

Collaborators

[object Object]